Arvind Remedies has established an Rs 250-crore manufacturing facility at Irungattukottai, near Chennai, in order to tap the US market. It has begun with testing and development of analgesic and cardiac generic drugs (tablets) at the plant, which will seek USFDA approval in next six months.
The company has also established a subsidiary in New Jersey to take care of its US strategy. It is likely to distribute its drugs in the US and also get into contract manufacturing for other American pharma companies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.50 |
| Dr. Reddys Lab | 1216.60 |
| Cipla | 1239.65 |
| Zydus Lifesciences | 928.00 |
| Lupin | 2300.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: